NDRA - Endra Life Sciences Q3 2022 Earnings Preview
- Endra Life Sciences ( NASDAQ: NDRA ) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.
- The consensus EPS Estimate is -$0.06
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward.
For further details see:
Endra Life Sciences Q3 2022 Earnings Preview